Latest News

Latest News

News from the World Hepatitis Alliance

How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...

What is the future for hepatitis treatments? And how we can fund hepatitis programmes?

28 Feb 2015 Bridie Taylor

Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

Need some inspiration for action? : Initiatives from WHA members

28 Feb 2015 Bridie Taylor

Together our voices are stronger and united we can tackle this global killer! The World Hepatitis Alliance is fortunate enough to be made up of...

How will 2015 be a defining year for the Alliance?

28 Feb 2015 Bridie Taylor

Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...

Assisting WHO in the development of a global strategy

31 Jan 2015 Bridie Taylor

World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...

World Hepatitis Alliance’s ever-growing membership base

31 Jan 2015 Bridie Taylor

Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...

Pages

News from infohep

HIV infection is a risk factor for liver fat accumulation

13 Aug 2018 Liz Highleyman
People living with HIV are about twice as likely to develop steatosis, or fat accumulation in the liver, even if they don't have hepatitis B or...

Supervised drug consumption sites offer opportunities for HCV testing and treatment

2 Aug 2018 Liz Highleyman
Most supervised drug consumption facilities offer hepatitis C virus (HCV) testing and referrals, but very few offer treatment, indicating that they...

Treat all with hepatitis C, World Health Organization recommends

30 Jul 2018 Keith Alcorn
Everyone with hepatitis C should receive treatment with a pan-genotypic regimen, the World Health Organization recommends in new guidelines issued in...

Unprecedented hepatitis C infection rates seen in gay men in Amsterdam PrEP programme

30 Jul 2018 Gus Cairns
Regular hepatitis C testing among the HIV-negative gay men and other men who have sex with men (MSM) participating in the Amsterdam pre-exposure...

DAA therapy for HCV patients without serious liver disease has significant survival benefits

26 Jul 2018 Michael Carter
Successful HCV treatment with direct-acting antivirals (DAAs) significantly reduces the risk of death for people who do not have advanced liver...

People with mental health and substance use issues still less likely to receive HCV therapy

24 Jul 2018 Michael Carter
The proportion of people with chronic hepatitis C virus (HCV) infection who receive antiviral treatment has increased substantially since the...

Advent of DAAs accompanied by dramatic improvement in survival after HCV-related liver transplant

18 Jul 2018 Michael Carter
Survival among people with hepatitis C virus (HCV) undergoing liver transplant has improved significantly since the introduction of direct-acting...

Ramucirumab targeted therapy extends liver cancer survival

9 Jul 2018 Liz Highleyman
Ramucirumab (Cyramza), a type of targeted therapy that slows tumour growth by blocking blood vessel formation, led to improved overall survival and...

New simplified scoring system identifies people with hepatitis B in need of treatment in Africa

2 Jul 2018 Keith Alcorn
Liver enzyme and hepatitis B 'e' antigen test results are sufficient to determine which people with hepatitis B need antiviral treatment...

Mixed results for experimental therapies for NASH

22 Jun 2018 Liz Highleyman
The recent International Liver Congress in Paris featured several presentations on investigational therapies for fatty liver disease. Drugs with a...